Arkolith/Insider Trading/INFI/Form 4

Evnin Anthony B

DirectorINFINITY PHARMACEUTICALS, INC. (INFI) · full profile →Form 4 · filed Jun 16, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 16, 2022Grant(A)46K$0.68$32K215K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 16, 2022Grant(A)45K—$045K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001140361-22-023338) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML